Feasibility of Affibody-Based Bioorthogonal Chemistry-Mediated Radionuclide Pretargeting.
Altai M, Perols A, Tsourma M, Mitran B, Honarvar H, Robillard M, Rossin R, ten Hoeve W, Lubberink M, Orlova A, Karlström AE, Tolmachev V.
Altai M, et al. Among authors: rossin r.
J Nucl Med. 2016 Mar;57(3):431-6. doi: 10.2967/jnumed.115.162248. Epub 2015 Dec 10.
J Nucl Med. 2016.
PMID: 26659353
Free article.